Quantitative Methods 2017

• Peak prevalence at different time points (e.g. weekly) during RT provides most accurate information on acute side effects • Essential information may be lost by using incidence and/or period prevalence • Assessment of baseline “toxicity” • Modelling studies on risk factors in general: • Include baseline “toxicity” as potential risk factor, OR • Exclude patients with baseline “toxicity” Key points